Cancer Of The Prostate clinical trials

Explore recruiting cancer of the prostate clinical trials.

Recruiting cancer of the prostate studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cancer Of The Prostate trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I, open-label, multi-center exploratory safety and efficacy study with PSMA, SSTR2 and GRPR targeted radioligand therapy in metastatic neuroendocrine prostate cancer

France, Germany, Italy, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomised phase 3 double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk, clinically localised prostate cancer.

Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cancer Of The Prostate trials by city

Cancer Of The Prostate in Toronto Cancer Of The Prostate in Vancouver Cancer Of The Prostate in Montreal Cancer Of The Prostate in Calgary Cancer Of The Prostate in Edmonton Cancer Of The Prostate in Ottawa Cancer Of The Prostate in Winnipeg Cancer Of The Prostate in Quebec City Cancer Of The Prostate in Hamilton Cancer Of The Prostate in Kitchener Cancer Of The Prostate in London Cancer Of The Prostate in Halifax Cancer Of The Prostate in New York Cancer Of The Prostate in Los Angeles Cancer Of The Prostate in Chicago Cancer Of The Prostate in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease